Navigation Links
Mach One Corporation Developing a Nasal, Hand Carried Product as Solution to Swine Flu (H1N1) Virus
Date:6/4/2009

Product Will Create A Barrier To Block The Attachment Of The Virus To The Nasal Membranes

BELGIUM, Wis., June 4 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), an innovative, global wellness solutions company, announces the development of a nasal immunoglobulins based product that can be hand carried and used as needed to form a mechanical barrier to block the attachment of the virus to the nasal membranes.

Peter Nash, Ph.D. and Chief Science Officer of Mach One Corporation said, "Having worked with the influenza virus group since 1974, the current strain of influenza Swine Flu (H1N1) appears to be similar to the swine influenza A (H1N1) triple reassortant virus, A/Wisconsin/87/2005 H1N1. This strain of virus is in the influenza virus group that is one of the most frequently occurring human illnesses and is responsible for substantial morbidity and economic loss. Viral inhibitors in the form of active immunoglobulins are effective anti-viral agents in vitro and in vivo. The primary site of attachment for these viruses appears to be in the nasal membrane. They spread from the nasal region into the pharyngeal region and can lead to lower respiratory infection leading to pneumonia and possible death. The proposed new product line could be engineered to be carried in one's pocket and used in the nasal passage. There is no need to be exposed to the risk of a needle. As needed, this type of product would allow for delivery to the direct area of the nasal membrane and block initial attachment in the nasal membrane. This gives a mechanical barrier to protect the person until their own immune system can build-up protection. This should slow the frequency of the virus in the environment."

Dr. Nash continued, "When blockage of the attachment of the virus is the objective, the immunoglobulin package is supplied to humans prior to exposure or immediately after an outbreak. The substantial pre
'/>"/>

SOURCE Mach One Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Memry Corporation Announces Preliminary Fiscal Fourth Quarter and 2007 Revenue
2. PeriCor Therapeutics Announces Closing of Licensing Agreement for Acadesine with Schering-Plough Corporation
3. AGA Medical Corporation Receives FDA and CE Mark Approvals for the AMPLATZER Vascular Plug II
4. Drug Royalty Corporation (DRC) Announces Acquisition Regarding PEG-INTRON(R) From Enzon Pharmaceuticals, Inc. (ENZN)
5. BioElectronics Corporation Announces Singapore and Malaysia Sales
6. Avicena Signs Worldwide Exclusive Distribution Agreement with RITA Corporation for its Proprietary Dermaceutical Compounds
7. DURECT Corporation to Present at the NewsMakers in the Biotech Industry Investment Conference
8. Insulet Corporation to Present at the Thomas Weisel Partners Healthcare Conference on September 6, 2007
9. Luminex Corporation to Present at Thomas Weisel Partners Healthcare Conference
10. Verenium Corporation to Present at the Upcoming Cowen and Company Clean Energy Conference
11. Enova Medical Launches Exos Corporation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... July 30, 2015 According to ... (Software, Molecular Modeling, PB/PK, PKPD, Trial Design, Toxicity Prediction, ... Preclinical, Clinical Trial), by End Users - Global Forecast ... expected to reach USD 2,107.99 million by 2020 from ... 15.29%. Browse more than ...
(Date:7/30/2015)... 30, 2015 Ascendis Pharma A/S (Nasdaq: ... its innovative TransCon technology to address significant unmet ... a six-month Phase 2 study to evaluate the ... in 53 treatment-naïve, pre-pubertal children with growth hormone ... pleased with the top-line results from our Phase ...
(Date:7/29/2015)... -- Sanofi, a global and diversified ... of 2015. CEO Olivier Brandicourt comments ... different businesses. Watch video interview and ... Topics covered in the interview include:  ... drivers - Diabetes - ...
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ... Company,s Chief Financial Officer has resigned.  The Company has ... Officer who retired in December 2014, as full time ... permanent successor.     Andy Ashworth began ... ensure a smooth transition.  Andy was the Company,s CFO ...
Breaking Biology Technology:Biosimulation Market Worth 2,107.99 Million USD by 2020 2Biosimulation Market Worth 2,107.99 Million USD by 2020 3Biosimulation Market Worth 2,107.99 Million USD by 2020 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 2Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 3Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 4Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 5Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 6Ascendis Pharma A/S Announces Positive Top-line Results from a Phase 2 Pediatric Study of Once-Weekly TransCon Growth Hormone for the Treatment of Growth Hormone Deficiency 7BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3
... Exchange between Physician Community and Leading Biotechnology and ... ... EMD Serono, Inc. announced,today that the company has adopted ... Interactions with Healthcare Professionals.,The revised voluntary Code, which builds on ...
... (NYSE:,WX), a leading pharmaceutical, biotechnology and medical device research,and ... United,States, today announced that it was awarded one of ... Dr. Ge Li was named one of the top ... China,Enterprise Innovation Forum held in Beijing last month., ...
... 10 Archi-Tech Systems, a,leading provider of ... DART(TM) PromoTrack, a new solution custom-designed to,rapidly ... and,prescriber promotions. Archi-Tech has tailored its proven ... pharmaceutical marketers, seamlessly,integrating disparate promotional campaign and ...
Cached Biology Technology:EMD Serono to Adopt Revised and Strengthened PhRMA Code 2EMD Serono to Adopt Revised and Strengthened PhRMA Code 3EMD Serono to Adopt Revised and Strengthened PhRMA Code 4WuXi PharmaTech (NYSE: WX) Named the Most Innovative Company in China and CEO Dr. Li the Most Innovative Leader of Chinese Enterprises 2Pharmaceutical Marketing Done Right: Archi-Tech Systems Unveils Version of Proven Analytics Solution for Campaign Management 2
(Date:7/31/2015)... Jul. 31, 2015 NXT-ID, Inc. (NASDAQ: NXTD ... focused on the growing mobile commerce market and creator ... filed provisional patent 62/198989 for ELECTRONIC CRYPTO-CURRENCY ... a method to advance crypto-currencies such as Bitcoin into ... common, uniform way to manage all payments.  ...
(Date:7/23/2015)... Mass., July 23, 2015 Aware, Inc. (NASDAQ: ... today reported financial results for its second quarter ended June ... of 2015 was $4.5 million, a decrease of 33% compared ... income in the second quarter of 2015 was $0.3 million, ... or $0.04 per diluted share, in the same period a ...
(Date:7/20/2015)...  Acuity Market Intelligence,s latest research "The Global ... and Privacy" forecasts that between 2014 and 2020 ... downloaded to smart mobile devices by 2.2 billion ... projected to generate more than $67.9 billion in ... period.    "Biometrics is at the ...
Breaking Biology News(10 mins):NXT-ID Patents Electronic Crypto-Currency Management Technology 2NXT-ID Patents Electronic Crypto-Currency Management Technology 3NXT-ID Patents Electronic Crypto-Currency Management Technology 4Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6Biometrics on Smart Mobile Devices to Redefine Digital Identity with 12.9 Billion Biometric App Downloads between 2014 and 2020 2
... techniques allow biologists to create quantitative, three-dimensional descriptions of ... the microscope. For example, they can accurately estimate ... length of a mass of blood vessels, or the ... of the brain. A new book from ...
... The injection of a tiny capsule containing heat-generating cells ... abdominal fat and initially lose about 20 percent of belly ... study were surprised to see that the injected cells even ... thermogenic cells, which use fat to generate heat. ...
... sources of information, <a target="_blank" href="http://en.wikipedia.org/wiki/Nucleic_acid_sequence,">DNA sequences ... To identify, proof, and discard compromised molecular data ... scientific endeavor - one that everyone generating sequence ... the sequences for research purposes. "Many researchers ...
Cached Biology News:Study in mice discovers injection of heat-generating cells reduces belly fat 2Study in mice discovers injection of heat-generating cells reduces belly fat 3Study in mice discovers injection of heat-generating cells reduces belly fat 4DNA sequences need quality time too - guidelines for quality control published 2
12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
...
...
12(S)-HETE-d8 is used as an internal standard for the quantification of 12(S)-HETE by stable isotope dilution mass spectrometry....
Biology Products: